Evert B. Schimmelpennink
CEO, President at LENZ Therapeutics, Inc. (LENZ)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return-30.5%
vs. S&P 500-48.1%
Beat the market0%
Paper profit on buys−$149K
Total bought / sold$251K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 30SEC | LENZLENZ Therapeutics, Inc. | Buy | 28,08977,289 held (+57%) | $8.95 | $251K | -59.3% |
- Buy
CEO, President Evert B. Schimmelpennink bought $251K of LENZ at $8.95 — first open-market purchase in our records; raises the stake by 57%.